Christopher D. M. Fletcher, MD, FRCPath
Harvard Medical School, Brigham and Women’s Hospital,
Dana-Farber Cancer Institute
Dr. Fletcher graduated from St. Thomas’s Hospital Medical School in London and obtained postgraduate qualifications from the Royal College of Pathologists (MRCPath - 1988) and the University of London (M.D. - 1991) in the United Kingdom. Dr. Fletcher has published extensively on the pathology of soft tissue tumors and is probably best known for his work challenging the diagnostic entities of malignant fibrous histiocytoma and hemangiopericytoma. He has also described for the first time a variety of lesions, including, among others, deep benign fibrous histiocytoma, angiomyofibroblastoma, retiform hemangioendothelioma, spindle cell liposarcoma, myoepithelial lesions of soft tissue, cellular angiofibroma and soft tissue angiofibroma. He has worked extensively on cytogenetic/morphologic correlations in soft tissue tumors. He is Chairman of the WHO Working Group on the classification of soft tissue tumours, having been senior editor of both the 2002 and most recent 2013 classifications. He has nearly 600 publications, including more than 400 original papers on soft tissue neoplasms, and several books, among which are the two-volume Diagnostic Histopathology of Tumors, now in its 4th edition. He has been the recipient of numerous honors and awards, is on the editorial board of 17 international journals and was President of the Association of Directors of Anatomic and Surgical Pathology from 2003-2006. He is currently President of USCAP and is former President of the International Society of Bone & Soft Tissue Pathology and the Arthur Purdy Stout Society. Dr. Fletcher is currently Professor of Pathology at Harvard Medical School, Vice Chair, Anatomic Pathology at Brigham and Women’s Hospital, Boston, Massachusetts and Chief of Onco-Pathology at the Dana-Farber Cancer Institute in Boston.